Brain SPECT Abstracts for Medication Effects and Treatment Response

Amen Clinics maintains a database of Abstracts relating to brain SPECT imaging. Use the search form below to find Abstracts by category, author and keyword.

All Categories Activation Addiction Aggression Alcohol, Drug Abuse Alzheimer's, Dementia, Parkinson's Disease Amyotrophic Lateral Sclerosis Anosagnosia Anoxia, hypoxia Anxiety, Panic, PTSD Attention Deficit Disorder, Learning Disabilities Auditory Processing Autism, Autistic Spectrum Disorder Autoimmune Disorders Before and After Bipolar Disorder Brain Death Brain Infections Brain Injury Carbon Monoxide Poisoning Cerebellar Problems Cerebellum Cerebral Atrophy Cerebral Hemorrhage Cerebral Hyperperfusion Syndrome Cerebral Vascular Disease Chemical Sensitivities Chemotherapy Chronic Fatigue Syndrome, Fibromyalgia Chronic Medical Condition Cognition Computer and Video Games Creativity CT Depression, Affective Disorders Diabetes and Blood Sugar Dissociative Identity Disorder Doppler Flow Meter Early Ischemic Change Eating Disorders EEG Effects of Chemotherapy Electroconvulsive Therapy Epilepsy Exercise fMRI Gambling Gender Identity Disorder General Glaucoma Head Trauma Headache Hemispatial Neglect Herbal Remedies Hormones Hyperbaric Oxygen Therapy Impulsivity Interventions Language Lupus Lyme Disease Medication Effects and Treatment Response Memory Loss, Cognitive Impairment, Dyslexia Movement Disorders MRI MRS Neural Circuitry Neuro Plasticity Neuroimaging Neurotoxic Chemical Exposure Night Eating Syndrome (NES) Normal Obsessive Compulsive, Spectrum Disorders Occupational Medicine Omega 3 Pain paroxysmal kinesigenic choreoathetosis Personality Disorder PET PET and Brain Trauma Psychotherapy QEEG Rendering and Reading SPECT Rhodiola Schizophrenia Seizures, Partial Seizures Selected Research by Daniel G. Amen, MD Serotonin Binding Studies Sleep Disorders Somatoform Disorder SPECT Sports Stroke Suicide Thyroid Tinnitus Tourette's Transcranial Magnetic Stimulation Treatment Resistant Treatments and Therapy Tumors Violence		Sort By   Date Authors Title
Search by Author	Title Keyword	Deep Keyword Search

Your search for Author = All, Title Keyword = All, and Deep Keyword = All returned the following results:

Records 1 - 25 of 224  First | « Previous | Next » | Last

Schizophrenic symptoms and SPECT abnormalities in a coeliac patient: regression after a gluten-free diet

Category: Medication Effects and Treatment Response

De Santis A, Addolorato G, Romito A, Caputo S, Giordano A, Gambassi G, Taranto C, Manna R, Gasbarrini G

Department of Internal Medicine, Catholic University, Rome, Italy

J Intern Med. 1997 Nov;242(5):421-3

Evaluation of cerebral blood flow reserve in patients with cerebrovascular disease by SPECT using technetium-99m-L, L-ethyl cysteinate dimer

Category: Medication Effects and Treatment Response

Hori A, Harada M, Nishitani H, Uno M

Department of Radiology, The University of Tokushima School of Medicine, Japan

J Med Invest 2002 Aug;49(3-4):134-41

Cerebral blood flow in patients with chronic cerebrovascular disease: effect of acetyl L-carnitine

Category: Medication Effects and Treatment Response

Postiglione A, Cicerano U, Soricelli A, De Chiara S, Gallotta G, Salvatore M, Mancini M

Institute of Internal Medicine and Metabolic Diseases, 2nd Medical School, University of Naples, Italy

Int J Clin Pharmacol Res 1990;10(1-2):129-32

In vivo olanzapine occupancy of muscarinic acetylcholine receptors in patients with schizophrenia

Category: Medication Effects and Treatment Response

Raedler TJ, Knable MB, Jones DW, Lafargue T, Urbina RA, Egan MF, Pickar D, Weinberger DR

Clinical Brain Disorders Branch, DIRP, NIMH, 20892, Bethesda, MD 20892-1379, USA

Neuropsychopharmacology 2000 Jul;23(1):56-68

A SPECT study of the effect of vagal nerve stimulation on thalamic activity in patients with epilepsy

Category: Medication Effects and Treatment Response

Ring HA, White S, Costa DC, Pottinger R, Dick JP, Koeze T, Sutcliffe J

St Bartholomew's and the Royal London School of Medicine, London, E1 1BB, UK

Seizure 2000 Sep;9(6):380-4

Changes of central benzodiazepine receptor density in the course of anticonvulsant treatment in temporal lobe epilepsy

Category: Medication Effects and Treatment Response

Staedt J, Stoppe G, Kogler A, Steinhoff BJ

Department of Psychiatry, Georg August University, Goettingen, Germany

Seizure 1995 Mar;4(1):49-52

Dopamine D2 receptor occupancy by olanzapine or risperidone in young patients with schizophrenia

Category: Medication Effects and Treatment Response

Lavalaye J, Linszen DH, Booij J, Reneman L, Gersons BP, van Royen EA

Department of Psychiatry, Academic Medical Centre, Amsterdam, The Netherlands

Psychiatry Res 1999 Nov 8;92(1):33-44

Using 99mTc HMPAO brain SPECT to evaluate the effects of anticoagulant therapy on regional cerebral blood flow in primary antiphospholipid antibody syndrome patients with brain involvement-a preliminary report.

Category: Medication Effects and Treatment Response

Sun SS, Liu FY, Tsai JJ, Yen RF, Kao CH, Huang WS.

Department of Nuclear Medicine, China Medicine College Hospital, Taichung, Taiwan.

Rheumatol Int. 2003 Nov;23(6):301-4. Epub 2003 Apr 09.

Methylphenidate decreases regional cerebral blood flow in normal human subjects.

Category: Medication Effects and Treatment Response

Wang GJ, Volkow ND, Fowler JS, Ferrieri R, Schlyer DJ, Alexoff D, Pappas N, Lieberman J, King P, Warner D, et al.

Medical Department, Brookhaven National Laboratory, Upton, New York, 11973

Life Sci 1994;54(9):PL143-PL146

Successful methylphenidate treatment of apathy after subcortical infarcts.

Category: Medication Effects and Treatment Response

Watanabe MD, Martin EM, DeLeon OA, Gaviria M, Pavel DG, Trepashko DW.

Department of Pharmacy Practice, University of Illinois-Chicago 60612, USA

J Neuropsychiatry Clin Neurosci 1995;7(4):502-504

Prolactin responses to acute clomipramine and haloperidol of male schizophrenic patients in a drug-free state and after treatment with clozapine or with olanzapine.

Category: Medication Effects and Treatment Response

Markianos M, Hatzimanolis J, Lykouras L, Christodoulou GN.

Athens University Medical School, Psychiatric Clinic, Eginition Hospital, Vas.Sophias 74, 11528, Athens, Greece

Schizophr Res 2002 Jul 1;56(1-2):11-7

Impact of cognitive rehabilitation therapy on neuropsychological impairments as measured by brain perfusion SPECT: a longitudinal study.

Category: Medication Effects and Treatment Response

Laatsch L, Jobe T, Sychra J, Lin Q, Blend M.

Department of Rehabilitation Medicine and Restorative Medical Sciences, University of Illinois, Chicago 60612, USA

Brain Inj 1997 Dec;11(12):851-63

Changes in regional cerebral blood flow abnormalities in late-life depression following response to electroconvulsive therapy.

Category: Medication Effects and Treatment Response

Awata S, Konno M, Kawashima R, Suzuki K, Sato T, Matsuoka H, Fukuda H, Sato M.

Department of Psychiatry, Tohoku University School of Medicine, Sendai, Japan

Psychiatry Clin Neurosci 2002 Feb;56(1):31-40

State changes in brain activity shown by the uptake of 99mTc-exametazime with single photon emission tomography in major depression before and after treatment.

Category: Medication Effects and Treatment Response

Goodwin GM, Austin MP, Dougall N, Ross M, Murray C, O'Carroll RE, Moffoot A, Prentice N, Ebmeier KP.

MRC Brain Metabolism Unit, Royal Edinburgh Hospital, Morningside Park, UK

J Affect Disord 1993 Dec;29(4):243-53

Brain blood flow changes in depressed patients treated with interpersonal psychotherapy or venlafaxine hydrochloride: preliminary findings.

Category: Medication Effects and Treatment Response

Martin SD, Martin E, Rai SS, Richardson MA, Royall R.

Affinity Research Unit, Cherry Knowle Hospital, Ryhope, Sunderland, SR2 0NB, England, UK

Arch Gen Psychiatry 2001 Jul;58(7):641-8, (Comment in: Arch Gen Psychiatry. 2001 Jul;58(7):649-50; Arch Gen Psychiatry. 2001 Jul;58(7):651-3)

SPECT and neuropsychological performance in severe depression treated with ECT.

Category: Medication Effects and Treatment Response

Mervaala E; Kononen M; Fohr J; Husso-Saastamoinen M; Valkonen-Korhonen M; Kuikka JT; Viinamaki H; Tammi AK; Tiihonen J; Partanen J; Lehtonen J.

Department of Clinical Neurophysiology, University Hospital of Kuopio, 70210 Kuopio, Finland

J Affect Disord 2001 Sep;66(1):47-58

SPECT monitoring of improved cerebral blood flow during long-term treatment of elderly patients with nootropic drugs.

Category: Medication Effects and Treatment Response

Dormehl IC, Jordaan B, Oliver DW, Croft S.

Atomic Energy Corporation, Institute for Life Sciences, University of Pretoria, Republic of South Africa

Clin Nucl Med 1999 Jan;24(1):29-34

CBF and cognitive evaluation of Alzheimer type patients before and after IMAO-B treatment: a pilot study.

Category: Medication Effects and Treatment Response

Agnoli A:

Department of Neurosciences, Faculty of Medicine, University La Sapienza, Rome, Italy

Eur Neuropsychopharmacol 1992 Mar;2(1):31-5

Double-blind olanzapine vs. haloperidol D2 dopamine receptor blockade in schizophrenic patients: a baseline-endpoint.

Category: Medication Effects and Treatment Response

Bernardo M, Parellada E, Lomena F, Catafau AM, Font M, Gomez JC, Lopez-Carrero C, Gutierrez F, Pavia J, Salamero M.

Department of Psychiatry, Hospital Clinic, Institut d'Investigacions Biomediques August Pi i Sunyer, Universitat de Barcelona, Barcelona, Spain

Psychiatry Res 2001 Aug 25;107(2):87-97

Increased cerebral blood flow in depressed patients responding to electroconvulsive therapy.

Category: Medication Effects and Treatment Response

Bonne O, Krausz Y, Shapira B, Bocher M, Karger H, Gorfine M, Chisin R, Lerer B.

Department of Psychiatry, Hadassah University Hospital, Jerusalem, Israel

J Nucl Med 1996 Jul;37(7):1075-80

SPECT mapping of cerebral activity changes induced by repetitive transcranial magnetic stimulation in depressed patients. A pilot study.

Category: Medication Effects and Treatment Response

Catafau AM, Perez V, Gironell A, Martin JC, Kulisevsky J, Estorch M, Carrio I, Alvarez E.

Nuclear Medicine Department, Hospital de Sant Pau, Pare Claret 167, 08025, Barcelona, Spain

Psychiatry Res 2001 May 30;106(3):151-60

Neurophysiologic predictors of treatment response to fluoxetine in major depression.

Category: Medication Effects and Treatment Response

Cook IA, Leuchter AF, Witte E, Abrams M, Uijtdehaage SH, Stubbeman W, Rosenberg-Thompson S, Anderson-Hanley C, Dunkin JJ.

Neuropsychiatric Institute/Hospital, Department of Psychiatry and Biobehavioral Sciences, UCLA School of Medicine, University of California, Los Angeles 90024-1759, USA

ATTENTION DEFICIT HYPERACTIVITY DISORDER: ASSESSMENT OF THE DOPAMINE TRANSPORTER BEFORE AND AFTER METHYLPHENIDATE TREATMENT AS MEASURED BY [99m Tc]Trodat-1.

Category: Medication Effects and Treatment Response

S. Dresel*, K.H. Krause, J. Krause, …

Effects of a single dose of the acetylcholinesterase inhibitor velnacrine on recognition memory and regional cerebral blood flow in Alzheimer's disease.

Category: Medication Effects and Treatment Response

Ebmeier KP:

MRC Brain Metabolism Unit, Royal Edinburgh Hospital, Morningside Park, UK

Psychopharmacology (Berl) 1992;108(1-2):103-9

Study of the influence of electroconvulsive therapy on the regional cerebral blood flow by HMPAO-SPECT.

Category: Medication Effects and Treatment Response

Elizagarate E, Cortes J, Gonzalez Pinto A, Gutierrez M, Alonso I, Alcorta P, Ramirez M, de Heredia JL, Figuerido JL.

Psychiatric Department, Hospital Santiago Apostol, Vitoria-Gasteiz, Spain

J Affect Disord 2001 Jun;65(1):55-9

Records 1 - 25 of 224   First | « Previous | Next » | Last